Consternation as NICE rejects Janssen MS drug PonvoryNICE has delivered its first verdict on NHS funding of Janssen’s oral multiple sclerosis drug Ponvory, and it’s Share XConsternation as NICE rejects Janssen MS drug Ponvoryhttps://pharmaphorum.com/news/consternation-as-nice-rejects-janssen-ms-drug-ponvory/
